These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31331775)

  • 1. Social mobilization for cholera prevention & control in India: Building on the existing framework.
    Gupta SS; Gupta SK
    Vaccine; 2020 Feb; 38 Suppl 1():A181-A183. PubMed ID: 31331775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review.
    Ray A; Sarkar K; Haldar P; Ghosh R
    Vaccine; 2020 Feb; 38 Suppl 1():A184-A193. PubMed ID: 31377080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges for Programmatic Implementation of Oral Cholera Vaccine in India.
    Chakraborty D; Kanungo S; Kumar Nandy R; Kumar Deb A; Kumar Mukhopadhyay A; Dutta S
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S754-S758. PubMed ID: 34668559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholera control and prevention: Role of evidence-based advocacy and communications.
    Nayyar A; Privor-Dumm L
    Vaccine; 2020 Feb; 38 Suppl 1():A178-A180. PubMed ID: 31262588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmatic Preparations and challenges for OCV introduction in India.
    Haldar P
    Vaccine; 2020 Feb; 38 Suppl 1():A175-A177. PubMed ID: 31307875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique.
    Démolis R; Botão C; Heyerdahl LW; Gessner BD; Cavailler P; Sinai C; Magaço A; Le Gargasson JB; Mengel M; Guillermet E
    Vaccine; 2018 Oct; 36(44):6497-6505. PubMed ID: 29174106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study.
    Lee EC; Chao DL; Lemaitre JC; Matrajt L; Pasetto D; Perez-Saez J; Finger F; Rinaldo A; Sugimoto JD; Halloran ME; Longini IM; Ternier R; Vissieres K; Azman AS; Lessler J; Ivers LC
    Lancet Glob Health; 2020 Aug; 8(8):e1081-e1089. PubMed ID: 32710864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Evaluation of a Government-Conducted Oral Cholera Vaccination Campaign-Haiti, 2013.
    Routh JA; Sreenivasan N; Adhikari BB; Andrecy LL; Bernateau M; Abimbola T; Njau J; Jackson E; Juin S; Francois J; Tohme RA; Meltzer MI; Katz MA; Mintz ED
    Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):37-42. PubMed ID: 29064362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-vaccine strategies for cholera prevention and control: India's preparedness for the global roadmap.
    Das M; Singh H; Girish Kumar CP; John D; Panda S; Mehendale SM
    Vaccine; 2020 Feb; 38 Suppl 1():A167-A174. PubMed ID: 31443992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.
    Franke MF; Ternier R; Jerome JG; Matias WR; Harris JB; Ivers LC
    Lancet Glob Health; 2018 Sep; 6(9):e1028-e1035. PubMed ID: 30103980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legacy of Polio-Use of India's Social Mobilization Network for Strengthening of the Universal Immunization Program in India.
    Deutsch N; Singh P; Singh V; Curtis R; Siddique AR
    J Infect Dis; 2017 Jul; 216(suppl_1):S260-S266. PubMed ID: 28838190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing cholera vaccination in Asia, Africa and Haiti: a meeting report.
    Hall RH; Sack DA
    Vaccine; 2015 Jan; 33(4):487-92. PubMed ID: 25437100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral cholera vaccine and integrated cholera control in Haiti.
    Ivers LC; Farmer PE; Pape WJ
    Lancet; 2012 Jun; 379(9831):2026-8. PubMed ID: 22656874
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathways to a policy for cholera control in India.
    Sekhar A; Kang G
    Vaccine; 2020 Feb; 38 Suppl 1():A157-A159. PubMed ID: 31266672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The history of OCV in India and barriers remaining to programmatic introduction.
    Mogasale V; Kanungo S; Pati S; Lynch J; Dutta S
    Vaccine; 2020 Feb; 38 Suppl 1():A41-A45. PubMed ID: 31982258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Knowledge and Practices Regarding Cholera, Water Treatment, Hygiene, and Sanitation Before and After an Oral Cholera Vaccination Campaign-Haiti, 2013-2014.
    Childs L; François J; Choudhury A; Wannemuehler K; Dismer A; Hyde TB; Yen CY; Date KA; Juin S; Katz MA; Kantor EF; Routh J; Etheart M; Wright T; Adrien P; Tohme RA
    Am J Trop Med Hyg; 2016 Dec; 95(6):1305-1313. PubMed ID: 27799642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera vaccine plan splits experts.
    Cyranoski D
    Nature; 2011 Jan; 469(7330):273-4. PubMed ID: 21248807
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.
    Wierzba TF; Kar SK; Mogasale VV; Kerketta AS; You YA; Baral P; Khuntia HK; Ali M; Kim YH; Rath SB; Bhattachan A; Sah B
    Vaccine; 2015 May; 33(21):2463-9. PubMed ID: 25850019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
    Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholera vaccine: new preventive tool for endemic countries.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2012 May; 8(5):682-4. PubMed ID: 22634452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.